{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:52:42Z","timestamp":1793908362433,"version":"4.8.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/100000062","name":"HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["K01DK103678"],"award-info":[{"award-number":["K01DK103678"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006812","name":"Center for Integrated Healthcare, U.S. Department of Veterans Affairs","doi-asserted-by":"crossref","award":["5IK2CX001030"],"award-info":[{"award-number":["5IK2CX001030"]}],"id":[{"id":"10.13039\/100006812","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"crossref","award":["12POST11920023"],"award-info":[{"award-number":["12POST11920023"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HHS | NIH | National Center for Advancing Translational Sciences","award":["UL1 TR001082"],"award-info":[{"award-number":["UL1 TR001082"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increased arterial stiffness and vascular endothelial dysfunction are important nontraditional cardiovascular risk factors evident in patients with CKD. Vascular oxidative stress and inflammation may contribute to vascular dysfunction in CKD, but direct evidence is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We assessed carotid-femoral pulse-wave velocity (arterial stiffness) and brachial artery flow-mediated dilation (vascular endothelial function) in participants with moderate-to-severe CKD (eGFR 15\u201359 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      ) and in healthy controls. Change in brachial artery flow-mediated dilation after an acute infusion of ascorbic acid to inhibit vascular oxidative stress (versus saline) was also measured. Protein expression of vascular endothelial cells collected from a peripheral vein and ELISAs to assess circulating markers were also performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 64 participants with CKD (mean\u00b1SD, 65\u00b18 years) and 17 healthy controls (60\u00b15 years) were included. Carotid-femoral pulse-wave velocity was greater in participants with CKD compared with healthy controls (1071\u00b1336 versus 732\u00b1128 cm\/s;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Brachial artery flow-mediated dilation was lower in participants with CKD compared with healthy controls (3.5%\u00b12.8% versus 5.5%\u00b13.2%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.02). Circulating inflammation markers (C-reactive protein and IL-6) were elevated in the CKD group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u22640.02). Endothelial cell protein expression of NADPH (intensity versus human umbilical vein endothelial cell control, 1.48\u00b10.28 versus 1.25\u00b10.31;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.05) was greater in participants with CKD. However, ascorbic acid significantly improved brachial artery flow-mediated dilation in control participants (saline, 5.5\u00b13.2; ascorbic acid, 6.8\u00b13.6); as compared with participants with CKD (saline, 3.5\u00b12.8; ascorbic acid, 3.6\u00b13.2) (group\u00d7condition interaction\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.04), suggesting vascular oxidative stress could not be overcome with ascorbic acid in participants with CKD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vascular oxidative stress is present in CKD, which cannot be overcome with acute infusion of ascorbic acid.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000962019","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T17:55:16Z","timestamp":1588096516000},"page":"501-509","source":"Crossref","is-referenced-by-count":33,"title":["Vascular Dysfunction, Oxidative Stress, and Inflammation in Chronic Kidney Disease"],"prefix":"10.34067","volume":"1","clinical-trial-number":[{"clinical-trial-number":"nct02209636","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9364-3256","authenticated-orcid":false,"given":"Kristen L.","family":"Nowak","sequence":"first","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jovanovich","sequence":"additional","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"},{"name":"Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Farmer-Bailey","sequence":"additional","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Bispham","sequence":"additional","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Struemph","sequence":"additional","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Malaczewski","sequence":"additional","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chonchol","sequence":"additional","affiliation":[{"name":"Anschutz Medical Campus, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"B1-20230821","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11606-010-1511-x","article-title":"Chronic kidney disease and the risk of end-stage renal disease versus death","volume":"26","author":"Dalrymple","year":"2011","journal-title":"J Gen Intern Med"},{"key":"B2-20230821","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and Epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"B3-20230821","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP57327","article-title":"Cardiovascular disease risk factors in chronic renal insufficiency","volume":"57","author":"Sarnak","year":"2002","journal-title":"Clin Nephrol"},{"key":"B4-20230821","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ncpneph0954","article-title":"Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease","volume":"4","author":"Kendrick","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"B5-20230821","first-page":"512","article-title":"Endothelial dysfunction and oxidative stress in chronic renal failure","volume":"17","author":"Ghiadoni","year":"2004","journal-title":"J Nephrol"},{"key":"B6-20230821","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/heart.83.2.205","article-title":"Abnormalities of endothelial function in patients with predialysis renal failure","volume":"83","author":"Thambyrajah","year":"2000","journal-title":"Heart"},{"key":"B7-20230821","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","article-title":"The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine","volume":"47","author":"Yilmaz","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B8-20230821","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/HJH.0b013e328331b81e","article-title":"Pulse wave velocity and vascular calcification at different stages of chronic kidney disease","volume":"28","author":"Temmar","year":"2010","journal-title":"J Hypertens"},{"key":"B9-20230821","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.ki.5000047","article-title":"Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease","volume":"69","author":"Briet","year":"2006","journal-title":"Kidney Int"},{"key":"B10-20230821","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.ajkd.2004.11.011","article-title":"Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease","volume":"45","author":"Wang","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B11-20230821","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"issue":"111","key":"B12-20230821","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ki.2008.516","article-title":"Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease","author":"Cachofeiro","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"B13-20230821","first-page":"413","article-title":"Oxidative stress and endothelial dysfunction in chronic kidney disease","volume":"92","author":"Costa-Hong","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"B14-20230821","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1152\/japplphysiol.00419.2011","article-title":"Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease","volume":"111","author":"Dupont","year":"2011","journal-title":"J Appl Physiol (1985)"},{"key":"B15-20230821","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1046\/j.1523-1755.2003.00852.x","article-title":"Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure","volume":"63","author":"Cross","year":"2003","journal-title":"Kidney Int"},{"key":"B16-20230821","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ckj\/sfx158","article-title":"Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease","volume":"11","author":"Gillis","year":"2018","journal-title":"Clin Kidney J"},{"key":"B17-20230821","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1681\/ASN.2016040453","article-title":"IL-1 inhibition and vascular function in CKD","volume":"28","author":"Nowak","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B18-20230821","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B19-20230821","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/HYPERTENSIONAHA.110.150821","article-title":"Ultrasound assessment of flow-mediated dilation","volume":"55","author":"Harris","year":"2010","journal-title":"Hypertension"},{"key":"B20-20230821","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.05850518","article-title":"Vascular dysfunction, oxidative stress, and inflammation in autosomal dominant polycystic kidney disease","volume":"13","author":"Nowak","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"88","key":"B21-20230821","first-page":"51478","article-title":"Assessment of vascular function in patients with chronic kidney disease","author":"Jablonski","year":"2014","journal-title":"J Vis Exp"},{"key":"B22-20230821","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.HYP.0000128420.01881.aa","article-title":"Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: The Framingham Heart study","volume":"43","author":"Mitchell","year":"2004","journal-title":"Hypertension"},{"key":"B23-20230821","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1113\/jphysiol.2003.057042","article-title":"Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing","volume":"556","author":"Eskurza","year":"2004","journal-title":"J Physiol"},{"key":"B24-20230821","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.RES.83.9.916","article-title":"Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations","volume":"83","author":"Jackson","year":"1998","journal-title":"Circ Res"},{"key":"B25-20230821","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/01.RES.0000269183.13937.e8","article-title":"Direct evidence of endothelial oxidative stress with aging in humans: Relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB","volume":"100","author":"Donato","year":"2007","journal-title":"Circ Res"},{"key":"B26-20230821","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYP.0000000000000033","article-title":"Recommendations for improving and standardizing vascular research on arterial stiffness: A scientific statement From the American Heart association","volume":"66","author":"Townsend","year":"2015","journal-title":"Hypertension"},{"key":"B27-20230821","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jacc.2012.09.010","article-title":"Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged\/older adults with moderately elevated systolic blood pressure","volume":"61","author":"Jablonski","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B28-20230821","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYP.0000000000000033","article-title":"Recommendations for improving and standardizing vascular research on arterial stiffness: A scientific statement from the American Heart association","volume":"66","author":"Townsend","year":"2015","journal-title":"Hypertension"},{"key":"B29-20230821","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2013-2183","article-title":"Essential role of estrogen for improvements in vascular endothelial function with endurance exercise in postmenopausal women","volume":"98","author":"Moreau","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B30-20230821","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0735-1097(97)00536-6","article-title":"Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus","volume":"31","author":"Timimi","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"B31-20230821","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.97.22.2222","article-title":"Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension","volume":"97","author":"Taddei","year":"1998","journal-title":"Circulation"},{"key":"B32-20230821","first-page":"H1644","article-title":"Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: Effect of vitamin C","volume":"273","author":"Motoyama","year":"1997","journal-title":"Am J Physiol"},{"key":"B33-20230821","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/HYPERTENSIONAHA.107.101014","article-title":"Importance of measuring the time course of flow-mediated dilatation in humans","volume":"51","author":"Black","year":"2008","journal-title":"Hypertension"},{"key":"B34-20230821","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cpf.12092","article-title":"Preserved flow-mediated dilation but delayed time-to-peak diameter in individuals with metabolic syndrome","volume":"34","author":"Fernandes","year":"2014","journal-title":"Clin Physiol Funct Imaging"},{"key":"B35-20230821","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.atherosclerosis.2007.12.036","article-title":"Endothelial dysfunction or dysfunctions? Identification of three different FMD responses in males with type 2 diabetes","volume":"200","author":"Irace","year":"2008","journal-title":"Atherosclerosis"},{"key":"B36-20230821","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1159\/000226227","article-title":"Adjusting flow-mediated dilation for shear stress stimulus allows demonstration of endothelial dysfunction in a population with moderate cardiovascular risk","volume":"46","author":"Padilla","year":"2009","journal-title":"J Vasc Res"},{"key":"B37-20230821","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1152\/japplphysiol.01245.2003","article-title":"Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans","volume":"97","author":"Pyke","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"B38-20230821","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.HYP.0000137305.77635.68","article-title":"Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart study [published correction appears in Hypertension 45: e9, 2005]","volume":"44","author":"Mitchell","year":"2004","journal-title":"Hypertension"},{"key":"B39-20230821","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1358863X08095154","article-title":"Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome","volume":"13","author":"Title","year":"2008","journal-title":"Vasc Med"},{"key":"B40-20230821","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2006.10.058","article-title":"Arterial reactivity in lower extremities is progressively reduced as cardiovascular risk factors increase: Comparison with upper extremities using magnetic resonance imaging","volume":"49","author":"Silber","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B41-20230821","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1053\/j.ajkd.2008.04.027","article-title":"Relations of measures of endothelial function and kidney disease: The Framingham Heart study","volume":"52","author":"Foster","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B42-20230821","doi-asserted-by":"crossref","first-page":"H57","DOI":"10.1152\/ajpheart.00980.2008","article-title":"Does arterial shear explain the magnitude of flow-mediated dilation?: A comparison between young and older humans","volume":"296","author":"Thijssen","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B43-20230821","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2215\/CJN.10681210","article-title":"Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease","volume":"6","author":"Yilmaz","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B44-20230821","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ajh\/hpw164","article-title":"Inflammation and arterial stiffness in chronic kidney disease: Findings From the CRIC study","volume":"30","author":"Peyster","year":"2017","journal-title":"Am J Hypertens"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000962019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:56:52Z","timestamp":1786478212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000962019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000962019","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}